ILMN showing weakness in front of major support Fundamentals:
Illumina made a disappointing start to first-quarter 2016 missing the estimates. Also, rising costs has potential to hamper its growth significantly. This rise in higher operating expenses impacted Ilumina’s cash flow reserve in the reported quarter.
Technicals:
In the mid of summer 2015 the price of stock accelerated with top $242. But big, engulfing, bear candle ended this run to the sky. Then it broke major trend line and deeper correction started. Then, it built sereis of lower highs, which mean that bear are in control. And now, we are sitting in front of major support $130 after dissapointing earnings.
Trade Management:
Break down of major support at $130 and hold below for a few days will trigger Short Entry. Shouldn't go back above $144.50, otherwise it will be break out failure. Respective Target is $92, which make this trade attractive from Risk/Reward point of view.
Market:
$IBB - ETF for bios is underperforming the market. And overall market ($SPY) is building Head&Shoulders pattern (now, we are in right shoulder). That also supports this idea.
